دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS
Kader Cetin Gedik, Lovro Lamot, Micol Romano, Erkan Demirkaya, David Piskin, Sofia Torreggiani, Laura A Adang, Thais Armangue, Kathe Barchus, Devon R Cordova, Yanick J Crow, Russell C Dale, Karen L Durrant, Despina Eleftheriou, Elisa M Fazzi, Marco Gattorno, Francesco Gavazzi, Eric P Hanson, Min Ae Lee-Kirsch, Gina A Montealegre Sanchez, Bénédicte Neven, Simona Orcesi, Seza Ozen, M Cecilia Poli, Elliot Schumacher, Davide Tonduti, Katsiaryna Uss, Daniel Aletaha, Brian M Feldman, Adeline Vanderver, Paul A Brogan, Raphaela Goldbach-Mansky
doi : 10.1136/annrheumdis-2021-221814
May 2022 - Volume 81 - 5
Call for action in ANCA-associated vasculitis and lupus nephritis: promises and challenges of SGLT-2 inhibitors
Marcus Säemann, Andreas Kronbichler
Marking the 50th anniversary of a seminal paper in rheumatology: did Baruj Benacerraf and Hugh McDevitt get it right?
James Todd Rosenbaum, Tejpal Gill, Tammy M Martin, Marcia Friedman, Reid Thompson
Baricitinib further enhances disease-modifying effects by uncoupling the link between disease activity and joint structural progression in patients with rheumatoid arthritis
Pedro Lopez-Romero, Inmaculada de la Torre, Ewa Haladyj, Daniel Aletaha, Josef S Smolen
Anti-RNP antibodies are associated with the interferon gene signature but not decreased complement levels in SLE
Erika L Hubbard, David S Pisetsky, Peter E Lipsky
Proteogenomic analysis of the autoreactive B cell repertoire in blood and tissues of patients with Sjögren’s syndrome
Mathijs G A Broeren, Jing J Wang, Giulia Balzaretti, Patricia J T A Groenen, Barbera D C van Schaik, Tim Chataway, Charlotte Kaffa, Sander Bervoets, Konnie M Hebeda, Gergana Bounova, Ger J M Pruijn, Thomas P Gordon, Niek De Vries, Rogier M Thurlings
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
Maria C Cid, Sebastian H Unizony, Daniel Blockmans, Elisabeth Brouwer, Lorenzo Dagna, Bhaskar Dasgupta, Bernhard Hellmich, Eamonn Molloy, Carlo Salvarani, Bruce C Trapnell, Kenneth J Warrington, Ian Wicks, Manoj Samant, Teresa Zhou, Lara Pupim, John F Paolini
Psoriasis rate is increased by the exposure to TNF inhibition in children with JIA
Yongdong Zhao, Erin Sullivan, Mary Beth Son, Timothy Beukelman
Osteoarthritis endotype discovery via clustering of biochemical marker data
Federico Angelini, Paweł Widera, Ali Mobasheri, Joseph Blair, André Struglics, Melanie Uebelhoer, Yves Henrotin, Anne CA Marijnissen, Margreet Kloppenburg, Francisco J Blanco, Ida K Haugen, Francis Berenbaum, Christoph Ladel, Jonathan Larkin, Anne C Bay-Jensen, Jaume Bacardit
Mechanical overloading promotes chondrocyte senescence and osteoarthritis development through downregulating FBXW7
Haiyan Zhang, Yan Shao, Zihao Yao, Liangliang Liu, Hongbo Zhang, Jianbin Yin, Haoyu Xie, Kai Li, Pinglin Lai, Hua Zeng, Guozhi Xiao, Chun Zeng, Daozhang Cai, Xiaochun Bai
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Michael Bonelli, Daniel Mrak, Selma Tobudic, Daniela Sieghart, Maximilian Koblischke, Peter Mandl, Barbara Kornek, Elisabeth Simader, Helga Radner, Thomas Perkmann, Helmuth Haslacher, Margareta Mayer, Philipp Hofer, Kurt Redlich, Emma Husar-Memmer, Ruth Fritsch-Stork, Renate Thalhammer, Karin Stiasny, Stefan Winkler, Josef S Smolen, Judith H Aberle, Markus Zeitlinger, Leonhard X Heinz, Daniel Aletaha
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
Pedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, Elsa F Mateus, Kimme L Hyrich, Laure Gossec, Loreto Carmona, Ana Rodrigues, Bernd Raffeiner, Catia Duarte, Eric Hachulla, Eric Veillard, Eva Strakova, Gerd R Burmester, Gözde Kübra Yardımcı, Jose A Gomez-Puerta, Julija Zepa, Lianne Kearsley-Fleet, Ludovic Trefond, Maria Cunha, Marta Mosca, Martina Cornalba, Martin Soubrier, Nicolas Roux, Olivier Brocq, Patrick Durez, Richard Conway, Tiphaine Goulenok, Johannes WJ Bijlsma, Iain B McInnes, Xavier Mariette
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis
Ana Cristina Medeiros-Ribeiro, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Henrique Carriço da Silva, Carla G S Saad, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Carlo Scognamiglio Renner Araujo, Tatiane Lie Nakai, Clóvis Artur Silva, Tatiana Pedrosa, Léonard de Vinci Kanda Kupa, Matheus Santos Rodrigues Silva, Guilherme Guimarães Moreira Balbi, Esper Georges Kallas, Nádia Emi Aikawa, Eloisa Bonfa
Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases
Jerome Hadjadj, Delphine Planas, Amani Ouedrani, Solene Buffier, Laure Delage, Yann Nguyen, Timothée Bruel, Marie-Claude Stolzenberg, Isabelle Staropoli, Natalia Ermak, Laure Macraigne, Caroline Morbieu, Soledad Henriquez, David Veyer, Hélène Péré, Marion Casadevall, Luc Mouthon, Frederic Rieux-Laucat, Lucienne Chatenoud, Olivier Schwartz, Benjamin Terrier
Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study
Denis Mongin, Kim Lauper, Axel Finckh, Thomas Frisell, Delphine Sophie Courvoisier
Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
Mayan Teles, Caoilfhionn M Connolly, Sarah Frey, Teresa Po-Yu Chiang, Jennifer J Alejo, Brian J Boyarsky, Ami A Shah, Jemima Albayda, Lisa Christopher-Stine, William A Werbel, Dorry L Segev, Julie J Paik
Management of contemporary early undifferentiated arthritis: data on EULAR’s recommendation on the risk of persistent disease
Nikolet K den Hollander, Marloes Verstappen, Tom WJ Huizinga, Annette van der Helm-van Mil
Managing the selection of placebo group switched to experimental treatment group in post-randomised controlled trial extension studies
Maya H Buch, Walter P Maksymowych, Maarten Boers
Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled pattern
Jean-Baptiste Vulsteke, Yves Piette, Carolien Bonroy, Patrick Verschueren, Daniel Blockmans, Steven Vanderschueren, Kristl G Claeys, Petra De Haes, Jan Leo Lenaerts, Wim A Wuyts, Takashi Matsushita, Vanessa Smith, Ellen De Langhe, Xavier Bossuyt
Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series
Peter Kvacskay, Wolfgang Merkt, Janine Günther, Norbert Blank, Hanns-Martin Lorenz
Increasing incidence of autoantibody-negative RA is replicated and is partly explained by an aging population
Xanthe M E Matthijssen, Tom W J Huizinga, Annette H M van der Helm-van Mil
Response to: ‘Increasing incidence of autoantibody-negative RA is replicated and is partly explained by an aging population’ by Matthijssen et al
Elena Myasoedova, John Davis, Eric L Matteson, Cynthia S Crowson
Comment on: ‘Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population’ by Kishikawa et al
Kaori Kitamura, Hiroshi Shionoya, Kuniaki Terato, Suguru Suzuki, Richio Fukai, Shinichi Uda, Chiyuki Abe, Hiromitsu Takemori, Keita Nishimura, Hisashi Baba, Takaki Waritani, Kou Katayama
Response to: ‘Comment on ‘Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population’ by Kishikawa et al.’ by Kitamura et al
Toshihiro Kishikawa, Yuichi Maeda, Takuro Nii, Yukinori Okada
Neuroinflammatory events after anti-TNFα therapy
Evripidis Kaltsonoudis, Eleftherios Pelechas, Paraskevi V Voulgari, Alexandros A Drosos
Response to: ‘Neuroinflammatory events after anti-TNFα therapy’ by Kaltsonoudis et al
Tine Iskov Kopp, Bénédicte Delcoigne, Elizabeth V Arkema, Melinda Magyari, Henning Locht, Finn Thorup Sellebjerg, Rene Lindholm Cordtz, Dorte V Jensen, Johan Askling, Lene Dreyer
Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus
Chia-Ying Wu, Magdalene Tan, Jing-Yang Huang, Jeng-Yuan Chiou, James Cheng-Chung Wei
Response to: ‘Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus’ by Wu et al
Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Physician’s global assessment is often useful in SLE, but not always: the case of clinical remission
Margherita Zen, Francesca Saccon, Mariele Gatto, Andrea Doria
Response to: ‘Phsician's global assessment is often useful in SLE, but not always: the case of clinical remission’ by Zen et al
Anca Askanase, Shereen Oon, Molla Huq, Alicia Calderone, Eric F Morand, Mandana Nikpour, Cynthia Aranow
Physician global assessment in systemic lupus erythematosus: can we rely on its reliability?
Elisabetta Chessa, Matteo Piga, Laurent Arnaud
Response to: ‘Physician global assessment in systemic lupus erythematosus: can we rely on its reliability?’ by Chessa et al
Anca Askanase, Shereen Oon, Molla Huq, Alicia Calderone, Eric F Morand, Mandana Nikpour, Cynthia Aranow
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopaenic purpura
Wenhui Xie, Zhuoli Zhang
Response to ‘Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura’ by Xie and Zhang
Fang-Xiao Zhu, Jing-Yang Huang, Qing-Qing Wen, James Cheng-Chung Wei
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a need for a more accurate control group?
Philippe Mertz, Laurent Arnaud
Response to: ‘Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a need for a more accurate control group?’ by Mertz and Arnaud
Fang Xiao Zhu, Jing-Yang Huang, Wen Qingqing, James Cheng Chung Wei
Associations of regular glucosamine use with all-cause and cause-specific mortality: causality assumptions need to be checked
Saeid Safiri, Mohammad Ali Mansournia
Response to: ‘Associations of regular glucosamine use with all-cause and cause-specific mortality: causality assumptions need to be checked’ by Safiri and Mansournia
Zhi-Hao Li, Qing-Mei Huang, Chen Mao
Response to: ‘Finding the right one’ by Zanwar
Thomas Renson, Filip E Van den Bosch, Dirk Elewaut
